From: ForgIng New paths in DIabetes PrevenTion (FINDIT): Study Protocol for a Randomized Controlled Trial
Inclusion Criteria a | Exclusion Criteria |
• Receives primary care at the Ann Arbor VA Medical Center | • Age >75 yearsa |
• BMI ≥30 kg/m2 or • BMI ≥25 kg/m2 with any of the following: | • Type 1 diabetesa,b (ICD-9 250 or ICD-10 E10.9) |
 • Hypertension (ICD-9 401 or ICD-10 I10) | • Type 2 diabetesa,b (ICD-9 250 or ICD-10 E11) |
 • Hyperlipidemia (ICD-9 272.4 or ICD-10 E78.5) | • Dementiaa (ICD-9 290 or ICD-10 F03) |
 • Hypoalphalipoproteinemia (ICD-9 272.5 or ICD-10 E78.6) | • End-stage renal diseasea,b (ICD-9 585.6 or ICD-10 N18.6) |
 • Coronary artery disease (ICD-9 414.01 or ICD-10 I25.119) | • Severe chronic obstructive pulmonary disease (ICD-9 496 or ICD-10 J44)a,b |
 • Peripheral vascular disease (ICD-9 443.9 or ICD-10 I73.9) | • Receiving chemotherapyb |
 • Hypertriglyceridemia (ICD-9 272.1 or ICD-10 E78.1) | • New York Heart Association Class III or IV congestive heart failure (ICD-9 428 or ICD-10 I50.20 or ICD-10 I50.30)a,b |
 • Past HbA1c of 5.7 - 6.4 | • Pregnant or planning to become pregnant in the next yearb |
 • Impaired fasting glucose (ICD-9 790.21 or ICD-10 R73.01) | • Stroke or myocardial infarction in the past 6 monthsb |
 • Impaired glucose tolerance (ICD-9 790.22 or ICD-10 R73.02) | • Cirrhosis (ICD-9 571 or ICD-10 K74.60)a |
 • Polycystic ovary syndrome (ICD-9 256.4 or ICD-10 E28.2) | • HbA1c test in the past 12 monthsa |